FIELD: medicine.
SUBSTANCE: invention relates to a method for treating primary focal segmental glomerulosclerosis (FSGS) in a patient in need thereof, including prescribing an effective amount of a compound by the Formula I or a pharmacologically acceptable salt thereof to the patient. In the general Formula I, R1 is a halogen; R2 is a C1-6haloalkyl; R3 is a halogen or C1-6 alkyl; R4 is hydrogen; each R5 is independently a C1-6 alkyl, -OH or -NH2; n is 0; and
each of A1 and A2 is -CH- ; and A3 is -N-.
Formula I
EFFECT: developed method for treating FSGS.
15 cl, 11 dwg, 3 ex
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING HEPATIC FIBROSES | 2017 |
|
RU2740902C2 |
| SOLUBLE C5aR ANTAGONISTS | 2017 |
|
RU2748260C2 |
| THERAPEUTIC COMPOUNDS AND COMPOSITIONS AND METHODS OF USING THEM | 2018 |
|
RU2769696C2 |
| MORPHOLINO-SUBSTITUTED DERIVATIVES OF UREA OR CARBAMATE AS MTOR INHIBITORS | 2012 |
|
RU2616619C2 |
| 2-PYRAZINONE DERIVATIVES FOR TREATING DISEASES OR CONDITIONS WHERE INHIBITING NEUTROPHIL ELASTASE ACTIVITY IS USEFUL | 2007 |
|
RU2448098C2 |
| SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2513636C2 |
| METHOD OF TREATING C3-GLOMERULOPATHY | 2017 |
|
RU2742888C2 |
| SOME CHEMICAL COMPOUNDS, COMPOSITIONS AND METHODS | 2010 |
|
RU2582676C2 |
| SOME CHEMICAL STRUCTURES, COMPOSITIONS AND METHODS | 2009 |
|
RU2537549C2 |
| DERIVATIVES OF ISOTHIOUREA AND METHOD OF THEIR PRODUCTION, THEIR APPLICATION AND PHARMACEUTICAL COMPOSITION | 2005 |
|
RU2376297C2 |
